Introduction: For health care policy organisers and programme administrators, the epidemiology of viral hepatitis during pregnancy is of high significance. Viral hepatitis B, C, and Human Immunodeficiency Virus (HIV) are among the most common globally occurring blood-borne infections with great clinical consequences. Children born to these pregnant women are at high risk for such viral hepatitis infections if these infections remain unidentified and untreated among HIV-infected pregnant women. Aims: The objective of the study was to establish the sero-prevalence of HBV and HCV among pregnant women infected with HIV in Abuja, Nigeria. Methodology: A cross-sectional study was studied at the National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria, among 330 HIV-infected pregnant women starting antiretroviral therapy (ART). The women were tested for antibodies to HBV and HCV. Initially, the specialists in Public Health and Virology validated a well-structured self-administered questionnaire used in this research. Prior to hiring/enrollment, the pre-tested questionnaire was used to collect socio-demographic data. The data was analysed using statistical solutions for goods and services (SPSS) (version 20.0). Results: Of the 330 pregnant women infected with HIV, 90 (27.3 percent) were positive for HBV, while 5 (1.5 percent) were positive for HCV (p = 0.42). In the age group of 20-29, the highest prevalence was observed. None of the patients did, however, test positive for both HBV and HCV. Conclusion: The results of this study showed that viral hepatitis infection is widespread and will place a greater political and socio-economic burden on infected people and dynamic communities, resulting in a major public health challenge. In order to mitigate epidemics at both regional and national levels, coordinated measures, such as initiatives and clear intervention policies, should also be placed in place.
Author(s) Details
Y. Ya’aba
Department
of Microbiology and Biotechnology, National Institute for Pharmaceutical
Research and Development (NIPRD) Abuja, Nigeria and Department of Microbiology,
Federal University Lafia, Nasarawa State, Nigeria.
S. B. Mohammed
Department
of Microbiology and Biotechnology, National Institute for Pharmaceutical
Research and Development (NIPRD) Abuja, Nigeria.
K. T. Olatunji
Department
of Microbiology and Biotechnology, National Institute for Pharmaceutical
Research and Development (NIPRD) Abuja, Nigeria.
M. Usoroh
Department
of Microbiology and Biotechnology, National Institute for Pharmaceutical
Research and Development (NIPRD) Abuja, Nigeria.
O. C. Daniel
Department
of Microbiology and Biotechnology, National Institute for Pharmaceutical
Research and Development (NIPRD) Abuja, Nigeria.
A. R. Abdulmumin
Department
of Microbiology, Ibrahim Badamasi Babangida University, Lapai, Niger State,
Nigeria.
J. G. Yakubu
View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/359
No comments:
Post a Comment